MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Pharmacological activation of Rev-erbα Provides Neuroprotection against Parkinson’s Disease

    L. Kou (Wuhan, China)

  • Phase 2 study evaluating safety, PK/PD, biomarkers, and efficacy of ANX005 in patients with Huntington’s disease (HD)

    R. Kumar, D. Claassen, A. Mongan, A. Grover, B. Hoehn, P. Lin, R. Arnold, E. Cahir-Mcfarland, T. Yednock, S. Keswani (Englewood, USA)

  • Phase-amplitude coupling between beta power and high frequency oscillations as a sensitive marker of parkinsonian state.

    M. Bočková, M. Lamoš, P. Daniel, M. Baláž, J. Chrastina, I. říha, I. Rektor (Brno, Czech Republic)

  • PHENOTYPIC DESCRIPTION OF TWO UNREPORTED FAMILIES WITH ANO3 DYSTONIA

    A. Trinchillo, G. de Joanna, M. Esposito (Naples, Italy)

  • Phenotypical and treatment response heterogeneity in a cohort of normal pressure hydrocephalus patients

    A. Di Maio, G. Lazzeri, F. Arienti, F. Ruggiero, F. Mameli, A. Di Fonzo, G. Franco (Milan, Italy)

  • Phosphorylated α-synuclein at serine residue 129 decreased in Parkinson’s disease patients taking 250mg of daily niacin for six months

    C. Wakade, M. Seamon, S. Purohit, J. Morgan, R. Chong (Augusta, USA)

  • Physical activity and incidence of Parkinson’s disease in French women from the E3N cohort study

    B. Portugal, F. Artaud, I. Degaey, E. Roze, G. Severi, M. Canonico, C. Proust-Lima, A. Elbaz (Villejuif, France)

  • Physician satisfaction from continuous telemonitoring in Parkinson’s disease

    A. Ntanis, G. Rigas, K. Tsamis, A. Tsakanika, F. Kanellos, S. Konitsiotis, D. Fotiadis (Ioannina, Greece)

  • Pilot case on the use of transcranial pulsed current stimulation(tPCS) in a patient with cervical dystonia(CD)

    JR. Chai, S. Bansal, D. Aur, O. Samotus, M. Jog (London, Canada)

  • Pilot study of narrative medicine (NM) interventions in facilitating advance care planning (ACP) in Parkinson’s disease (PD): a feasibility study

    J. Jiao, B. Lobb, A. Hiller (Portland, USA)

  • « Previous Page
  • 1
  • …
  • 107
  • 108
  • 109
  • 110
  • 111
  • …
  • 153
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley